ENTRY       D08870                      Drug
NAME        Belinostat (USAN/INN);
            Beleodaq (TN)
PRODUCT     BELEODAQ (Acrotech Biopharma)
FORMULA     C15H14N2O4S
EXACT_MASS  318.0674
MOL_WEIGHT  318.3477
CLASS       Antineoplastic
             DG03133  Histone deacetylase inhibitor
            Metabolizing enzyme substrate
             DG01638  CYP2A6 substrate
             DG01642  CYP2C9 substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
             DG02924  UGT substrate
              DG03183  UGT1A1 substrate
REMARK      ATC code: L01XH04
            Product: D08870<US>
EFFICACY    Antineoplastic, Histone deacetylase inhibitor
  DISEASE   Peripheral T-cell lymphoma [DS:H01892]
TARGET      HDAC [HSA:3065 3066 8841 9759 10014 10013 51564 55869 9734 83933 79885] [KO:K06067 K11404 K11406 K11407 K11408 K11405 K11409 K18671 K11418]
  PATHWAY   hsa04110(3065+3066)  Cell cycle
            hsa04330(3065+3066)  Notch signaling pathway
            hsa05200(3065+3066)  Pathways in cancer
METABOLISM  Enzyme: UGT1A1 [HSA:54658]; CYP2A6 [HSA:1548], CYP2C9 [HSA:1559], CYP3A4 [HSA:1576]
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L01 ANTINEOPLASTIC AGENTS
               L01X OTHER ANTINEOPLASTIC AGENTS
                L01XH Histone deacetylase (HDAC) inhibitors
                 L01XH04 Belinostat
                  D08870  Belinostat (USAN/INN) &lt;US&gt;
            USP drug classification [BR:br08302]
             Antineoplastics
              Molecular Target Inhibitors
               Belinostat
                D08870  Belinostat (USAN/INN)
            Drug groups [BR:br08330]
             Antineoplastic
              DG03133  Histone deacetylase inhibitor
               D08870  Belinostat
             Metabolizing enzyme substrate
              DG01638  CYP2A6 substrate
               D08870  Belinostat
              DG01642  CYP2C9 substrate
               D08870  Belinostat
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                D08870  Belinostat
              DG02924  UGT substrate
               DG03183  UGT1A1 substrate
                D08870  Belinostat
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Hydrolases (EC3)
               Histone deacetylase
                HDAC
                 D08870  Belinostat (USAN/INN) &lt;US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D08870
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D08870
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D08870
            Pharmacogenomic biomarkers [br08341.html]
             Polymorphisms and mutations affecting drug response
              D08870
DBLINKS     CAS: 414864-00-9
            PubChem: 96025553
            ChEBI: 61076
            PDB-CCD: 5OG
            LigandBox: D08870
ATOM        22
            1   C8y C    19.2500  -16.8000
            2   C8x C    19.2500  -18.2000
            3   C8x C    20.4624  -18.9000
            4   C8x C    21.6749  -18.2000
            5   C8y C    21.6749  -16.8000
            6   C8x C    20.4624  -16.1000
            7   S4a S    18.0376  -16.1000
            8   N1b N    16.8251  -15.4000
            9   O3c O    18.7430  -14.8779
            10  O3c O    17.3434  -17.3027
            11  C8y C    15.5940  -16.1110
            12  C8x C    14.3888  -15.4153
            13  C8x C    13.1765  -16.1154
            14  C8x C    13.1765  -17.5154
            15  C8x C    14.3817  -18.2111
            16  C8x C    15.5941  -17.5110
            17  C2b C    22.9060  -16.0890
            18  C2b C    24.1112  -16.7847
            19  C5a C    25.2935  -16.1019
            20  N1b N    26.4875  -16.7912
            21  O5a O    25.2935  -14.7002
            22  O1b O    27.6754  -16.1052
BOND        23
            1     1   2 2
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 2
            6     1   6 1
            7     1   7 1
            8     7   8 1
            9     7   9 2
            10    7  10 2
            11    8  11 1
            12   11  12 2
            13   12  13 1
            14   13  14 2
            15   14  15 1
            16   15  16 2
            17   11  16 1
            18    5  17 1
            19   17  18 2
            20   18  19 1
            21   19  20 1
            22   19  21 2
            23   20  22 1
///
